Engineered Lactococcus lactis secreting Flt3L and OX40 ligand for in situ vaccination-based cancer immunotherapy.
Zhu J, Ke Y, Liu Q, Yang J, Liu F, Xu R, Zhou H, Chen A, Xiao J, Meng F, Yu L, Li R, Wei J, Liu B.
Zhu J, et al. Among authors: liu b, liu q, liu f.
Nat Commun. 2022 Dec 3;13(1):7466. doi: 10.1038/s41467-022-35130-7.
Nat Commun. 2022.
PMID: 36463242
Free PMC article.